Skip to content
Research Article Open access CC BY 4.0

Patent Ductus Arteriosus Closure by Paracetamol in a Critical Preterm Infant after Late Recanalization

Abdelmonem Helal, Naif Alkhushi, M. O. Galal

Asian Journal of Research in Cardiovascular Diseases · pp. 112–116 · Published 1 Sep 2020

Abstract

Cyclooxygenase (COX) inhibitors form the first line of treatment for patent ductus arteriosus (PDA) in preterm neonates. However, their efficacy decreases with increasing postnatal age. Paracetamol can be used when COX inhibitors are contraindicated and in advanced postnatal age. We describe a late preterm neonate (five weeks postnatal age, 1550 g birth weight) with a hemodynamically significant PDA, where COX inhibitor therapy could not be initiated due to spontaneously perforated necrotizing enterocolitis that was treated surgically. At five weeks postnatal age and body weight of 1800 g intravenous paracetamol was started. Over a 3-day course, it led to complete closure of the PDA. With follow up three months after treatment, recanalization occurred but did not need further attention.

Paracetamol Patent Ductus Arteriosus (PDA) necrotizing enterocolitis preterm infant

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.